What is the recommended treatment for high-risk skin cancers using the Mohs (Micrographic Surgery) technique?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Mohs micrographic surgery is the recommended treatment for high-risk skin cancers, particularly basal cell carcinomas and squamous cell carcinomas located in cosmetically sensitive areas like the face, or for tumors that are large, aggressive, recurrent, or have ill-defined borders. This technique offers the highest cure rates (up to 99% for previously untreated cancers) while preserving the maximum amount of healthy tissue 1. The procedure involves surgically removing the visible tumor and a small margin of surrounding tissue, which is immediately examined under a microscope while the patient waits. If cancer cells are still present at the edges of the removed tissue, additional layers are excised from precisely where the cancer remains until all margins are clear of cancer cells.

Key Benefits of Mohs Micrographic Surgery

  • High cure rates for high-risk skin cancers
  • Preservation of maximum amount of healthy tissue
  • Can be performed under local anesthesia as an outpatient procedure
  • Recovery time varies based on the extent of surgery, but most patients can resume normal activities within a few days to weeks
  • Post-operative care includes keeping the wound clean, applying prescribed ointments, and protecting the area from sun exposure to prevent recurrence

Indications for Mohs Micrographic Surgery

  • High-risk basal cell carcinomas and squamous cell carcinomas
  • Tumors located in cosmetically sensitive areas like the face
  • Large, aggressive, recurrent, or ill-defined tumors
  • Tumors with high-risk features, such as perineural involvement or sarcomatoid/spindle cell growth patterns

Limitations of Mohs Micrographic Surgery

  • May not be suitable for tumors with aggressive histopathologic growth patterns poorly visualized with frozen sections
  • Tissue blocks from Mohs layers are not available for molecular testing or further evaluation of high-risk or unusual features by using paraffin sections
  • Requires careful selection of tumors appropriate for treatment with Mohs micrographic surgery and evaluation by frozen sections to minimize limitations 1.

From the Research

Mohs Technique for High-Risk Skin Cancers

The Mohs technique, also known as Mohs micrographic surgery (MMS), is a highly effective treatment for high-risk skin cancers, including cutaneous squamous cell carcinoma (SCC) and basal cell carcinoma.

  • Effectiveness of MMS: Studies have shown that MMS is effective in treating high-risk SCC, with low recurrence rates and disease-specific mortality 2, 3.
  • Advantages of MMS: MMS is a pathology-controlled surgery with high intrinsic value due to its low risk of recurrences, making it a recommended treatment for high-risk non-melanoma skin cancers 3.
  • Indications for MMS: MMS is particularly useful for treating skin cancers in critical sites, recurrent tumors, and tumors with aggressive histologic features 3, 4.
  • Treatment Outcomes: A study of 215 patients with high-risk SCC treated with MMS reported a local recurrence rate of 1.2% and a metastasis rate of 2.3% 2.
  • Comparison with Traditional Surgery: MMS has been shown to be superior to traditional surgery in treating high-risk non-melanoma skin cancers, with a lower risk of recurrences and better cosmetic outcomes 3.
  • Emerging Therapies: Recent studies have also explored the use of immunotherapies, such as PD-1 inhibitors and oncolytic viruses, in the treatment of high-risk cSCC, which may be used in conjunction with MMS 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.